Bora Pharmaceuticals Subsidiary Signs 10-Year Long-Term Manufacturing Agreement with Top 20 Global Pharma Company

AI Summary (NQ-processed)

Bora Corporation's subsidiary, Bora Pharmaceuticals Inc., has signed a 10-year long-term contract manufacturing agreement with a top 20 global pharmaceutical company. The agreement covers a range of services including development, manufacturing, packaging, and analysis. This strategic move strengthens Bora's position as a long-term CDMO partner for international pharmaceutical firms and is expected to positively impact future revenue and operational scale, furthering its expansion into new drug and biologics manufacturing.